MedCity News November 4, 2024
I met a mix of biotech and healthtech companies at HLTH affecting everything from drug development, drug efficacy to controlling specialty care costs and managing chronic diseases.
Large conferences are a perfect place to see what companies are working on, and the recently-concluded HLTH conference had its own share of companies touting their strengths and capabilities. Here are a few that I met for the first time or caught up with again after a while (in alphabetical order)
Brook Health
There’s no escaping AI – try as we all did at HLTH – but Brook Health’s plan is to use AI to extend the primary care provider’s relationship to the patient’s home for chronic disease management.
“We encapsulate everything that needs...
Today's Sponsors
Today's Sponsor